Abstract:antibody response for getting insights in the immune response related to H. pylori clearance.were randomly assigned to receive three intramuscular doses of the IVAC or placebo at 0, 1 and 2 months.One month after the third vaccination/placebo all subjects received the infective challenge with a well characterized CagA positive H. pylori strain.The primary end point for the presence of infection has been set at 12 weeks post challenge.Serum Anti-CagA, Anti-NAP, and Anti VacA antibodies (IgG) were quantified via ELISA in all subjects on a weekly base (visit V2-10).Results: All verum vaccinated subjects (n=19) responded with mounted immunoglobulin G antibody titers to all 3 antigens (CagA, VacA and NAP) until V10.Vaccinated subjects (n=11) that became H. pylori negative three months after challenge (V10) showed significantly earlier antibody response to CagA with highest titer at V4.In comparison, vaccinated H. pylori positive subjects (n=8) at V10 showed later antibody response with the maximum at V8 (p,0.05).Furthermore, vaccinated H. pylori negative subjects developed overall higher antibody titers to NAP and VacA in comparison to vaccinated H. pylori positive subjects.Interestingly, almost all subjects in the placebo group developed a late (V10) and weaker antibody response to CagA and VacA but not for NAP after challenge with H. pylori.Conclusion: The stronger CagA immune response in vaccinated subjects that became H. pylori negative during the observation period candidates as a possible predictive factor for the clearance of H. pylori after vaccination which includes a Cag antigen.Our results further provide interesting insights in the humoral immune response after challenge with H. pylori.

Sa1879 Helicobacter Pylori Cag a Rewires Arf6-ACAP4-ezrin Signaling Axis in Parietal Cell Secretion